Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Honor Health Resarch Institute, Scottsdale, Arizona Sarah Cannon Research Institute (SCRI) - Denver HealthONE Location, Denver, Colorado SCRI Oncology Partners, Nashville, Tennessee